Pitolisant delayed-release (Harmony Biosciences)

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NamePitolisant delayed-release (Harmony Biosciences)
Drug Alias NameHBS-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsNarcolepsyIdiopathic HypersomniaDisorders of Excessive Somnolence +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHarmony Biosciences Management Inc
China Registration ClassN/A

Develop Information

Active CompaniesHarmony Biosciences Management Inc
Inactive CompaniesN/A
Active IndicationsNarcolepsyIdiopathic HypersomniaDisorders of Excessive Somnolence +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A